Snityam Pharmaceuticals Private Limited
About Snityam Pharmaceuticals Private Limited
Data last updated:
Snityam Pharmaceuticals Private Limited was a private limited company based in Thane, Maharashtra, India, operated as a subsidiary of The Reliance Investment Company Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the international and diplomatic organisations segment of the public administration sector. It was incorporated on 16 July 1979.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1979PTC021471.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ravi Chettuvatty Menon and Anil Nivrutti Dumbre.
Its last annual general meeting (AGM) was held on 25 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at S/4 MIDC Tarapurboisar, Thane, Maharashtra, India – 401506.
As per the financials filed for FY 2017, the company reported a revenue of ₹22,361, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹1,192 (net margin -5.3%) and EBITDA of -₹1,192 (EBITDA margin -5.3%).
Company details
Contact details
Snityam Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS/4 MIDC Tarapurboisar, Thane, Maharashtra, India – 401506
- IndustryPublic Administration, Extra Territorial Organizations
To see the full contact details of Snityam Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Snityam Pharmaceuticals Private Limited
FY 2017 filings availableSnityam Pharmaceuticals Private Limited reported revenue of ₹22,361 (up 19% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 19% in the latest year. EBITDA rose 70% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹22,361 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1,192 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1,192 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -5.3% | ||
| Net Profit Margin | -5.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Snityam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Snityam Pharmaceuticals Private Limited
Snityam Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Chettuvatty Menon Also directs: S S Computer Services LLP, Lee Packaging Private Limited | Director | 11 Sep 2000 | 26 Years 1 Months | As last reported |
| Anil Nivrutti Dumbre | Director | 11 Sep 2000 | 26 Years 1 Months | As last reported |
Peer comparison
Snityam Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Camswin Pharmaceuticals Private Limited | ₹23,986 (FY 2024) | 10329.0% | Cuttack, Odisha, India | |||
| Rejuvin Pharmaceuticals Private Limited | ₹23,929 (FY 2025) | -73.0% | Kolkata, West Bengal, India | |||
| JRV Pharmaceuticals Private Limited | ₹23,059 (FY 2025) | -95.0% | Karnal, Haryana, India | |||
| Shuddha Pharmaceuticals Private Limited | ₹23,000 (FY 2025) | -85.0% | Pen, Maharashtra, India | |||
| Dli Pharmaceuticals India Private Limited | ₹22,513 (FY 2025) | -80.0% | Noida, Uttar Pradesh, India | |||
| Snityam Pharmaceuticals Private Limitedthis company | ₹22,361 (FY 2017) | -₹1,192 | -5.3% | 19.0% | Thane, Maharashtra, India | |
| Kirsud Pharmaceuticals Private Limited | ₹22,200 (FY 2025) | -67.0% | Mumbai, Maharashtra, India | |||
| Biorest Pharmaceuticals Private Limited | ₹22,000 (FY 2025) | -2.0% | Gurugram, Haryana, India | |||
| Galactic Pharmaceuticals Private Limited | ₹21,871 (FY 2019) | Yavatmal, Maharashtra, India | ||||
| Varystal Pharmaceuticals India Private Limited | ₹21,560 (FY 2024) | Bhagpat, Uttar Pradesh, India | ||||
| Kartavya Pharmaceuticals Private Limited | ₹21,542 (FY 2021) | -52.0% | Sangli, Maharashtra, India |
To see the full peer comparison of Snityam Pharmaceuticals Private Limited, buy the company report.
Auditor
Snityam Pharmaceuticals Private Limited is audited by A M GHELANI & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A M GHELANI & COMPANY | FY 2017 | 103173W |
Shareholding
The shareholding of Snityam Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Snityam Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Snityam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snityam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Snityam Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Snityam Pharmaceuticals Private Limited has 2 board changes on record since 2000: 2 appointments. The latest: Anil Nivrutti Dumbre was appointed as Director on 11 Sep 2000.
Frequently asked questions
Snityam Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Snityam Pharmaceuticals was a private limited company based in Thane, Maharashtra, India. The company worked in extra territorial organizations, within the public administration industry. It was incorporated on 16 July 1979 and is registered under CIN U99999MH1979PTC021471. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Snityam Pharmaceuticals was incorporated on 16 July 1979. It is registered with the Registrar of Companies, Mumbai.
Snityam Pharmaceuticals had 2 directors:
- Ravi Chettuvatty Menon - Director
- Anil Nivrutti Dumbre - Director
The CIN (Corporate Identification Number) of Snityam Pharmaceuticals is U99999MH1979PTC021471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Snityam Pharmaceuticals is at S4 MIDC Tarapurboisar, Thane, Maharashtra, India – 401506.
The latest financial statements of Snityam Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 25 September 2017. Year-wise statements from 2015 are in the company report.
Snityam Pharmaceuticals operated in the public administration industry, in the extra territorial organizations segment.
The peers of Snityam Pharmaceuticals by revenue are Camswin Pharmaceuticals Private Limited, Rejuvin Pharmaceuticals Private Limited, JRV Pharmaceuticals Private Limited, Shuddha Pharmaceuticals Private Limited, Dli Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Anil Nivrutti Dumbre was appointed as Director on 11 Sep 2000. Ravi Chettuvatty Menon was appointed as Director on 11 Sep 2000.
Snityam Pharmaceuticals can be reached at its registered office: S4 MIDC Tarapurboisar, Thane, Maharashtra, India – 401506.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
